These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14684234)

  • 21. The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases.
    Naumchik BM; Gupta A; Flanagan-Steet H; Steet RA; Cathey SS; Orchard PJ; Lund TC
    Cells; 2020 Jun; 9(6):. PubMed ID: 32517081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell therapies for the lysosomal storage diseases - the quintessential neurodegenerative diseases.
    Schwartz PH; Brick DJ
    Curr Stem Cell Res Ther; 2008 May; 3(2):88-98. PubMed ID: 18473875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism of action of cell therapy in hereditary diseases].
    Martinez-Morga M; Medina-Corvalan C; Pérez-García C; Bueno C; Martinez S
    Medicina (B Aires); 2020; 80 Suppl 2():2-6. PubMed ID: 32150704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development.
    Massaro G; Geard AF; Liu W; Coombe-Tennant O; Waddington SN; Baruteau J; Gissen P; Rahim AA
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Approaches in Lysosomal Storage Diseases.
    Fernández-Pereira C; San Millán-Tejado B; Gallardo-Gómez M; Pérez-Márquez T; Alves-Villar M; Melcón-Crespo C; Fernández-Martín J; Ortolano S
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy for lysosomal storage disorders.
    Beck M
    IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone marrow transplantation for lysosomal storage diseases].
    Imaizumi M
    Nihon Rinsho; 1995 Dec; 53(12):3083-8. PubMed ID: 8577063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy of lysosomal storage disorders.
    Salvetti A; Heard JM; Danos O
    Br Med Bull; 1995 Jan; 51(1):106-22. PubMed ID: 7767637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful hematopoietic stem cell transplantation in Farber disease.
    Vormoor J; Ehlert K; Groll AH; Koch HG; Frosch M; Roth J
    J Pediatr; 2004 Jan; 144(1):132-4. PubMed ID: 14722533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of a lysosomal deficiency by contact-mediated enzyme transfer after bone marrow transplantation.
    Bou-Gharios G; Adams G; Pace P; Warden P; Olsen I
    Transplantation; 1993 Oct; 56(4):991-6. PubMed ID: 8212223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current therapeutic strategies in lysosomal disorders].
    Kaminsky P; Lidove O
    Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on treatment of lysosomal storage diseases.
    Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV
    Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapeutic prospects for the glycosphingolipid lysosomal storage diseases.
    Platt FM; Butters TD
    Biochem Pharmacol; 1998 Aug; 56(4):421-30. PubMed ID: 9763217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell bone marrow transplantation in patients with metabolic storage diseases.
    Krivit W
    Adv Pediatr; 2002; 49():359-78. PubMed ID: 12214779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and emerging therapies for the lysosomal storage disorders.
    Pastores GM; Barnett NL
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
    Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
    Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.